Nike has agreed to a multi-year deal to become the official kit sponsor for the Mumbai Indians' men's and women's teams. While team staff will begin wearing branded gear this month, official player uniforms will feature the Nike Swoosh beginning in 2027. The move follows the apparel maker's earlier departure from sponsoring the Indian national cricket team in 2020. The partnership replaces outgoing supplier Skechers, which served as the franchise's kit partner from 2024 to 2026.
Key points
Top Indian Premier League franchises reportedly seek between Rs 40 crore and Rs 60 crore…: Top Indian Premier League franchises reportedly seek between Rs 40 crore and Rs 60 crore per season for front-of-jersey space.
The tournament's overall valuation expanded significantly from $4.13 billion in 2010 to $…: The tournament's overall valuation expanded significantly from $4.13 billion in 2010 to $9.6 billion during Nike's IPL hiatus.
Losing the Indian national cricket team contract to rival Adidas prompted Nike to secure…: Losing the Indian national cricket team contract to rival Adidas prompted Nike to secure franchise-level visibility.
Sources checked by our analysis pipeline: 1
NEW DELHI: On October 21, Nike and
Mumbai Indians (MI) entered into a multi-year partnership for the men's and women's teams, starting from 2027. MI staff are slated to sport the new gear this month, while women's and men's teams are expected to showcase it ahead of their respective seasons. This is Nike's first IPL kit deal since working with the now-defunct Deccan Chargers in 2008 - 18 years ago.
What makes this partnership unique to the current kit manufacturing deals with IPL franchises is that it will see the iconic Nike Swoosh on the Mumbai Indians jerseys. In the world of shirt sponsorships, where IPL franchises such as MI, Royal Challengers Bengaluru and Chennai Super Kings demand a reported Rs 40-60 crore per season for the front jersey, it is premium retail space.
"The partnership marks a significant step in Nike’s continued investment in cricket and reflects the brand’s long-term commitment to athletes, fans and the future of sport in India," said the company in a press note.
Before Nike, MI had Performax Activewear (2019-2024) and Skechers (2024-2026) as…
Wall Street expects the pharmaceutical giant to post $22.61 billion in revenue, powered by strong demand for its flagship diabetes and obesity treatments. These record profits have provided capital for an aggressive acquisition push into vaccines and psychedelic medicine. Investors are closely monitoring whether this momentum will maintain the company's edge over key rival Novo.
The strategic governance restructuring aligns with the company's shift toward an independent, board-led management structure. Independent director Sudarshan Sampathkumar will step into the non-executive chairman post, while Sanjay Sachdeva maintains executive leadership as managing director and chief executive. This planned evolution arrives on the heels of a corporate financial turnaround that prompted positive market sentiment.